Ulcerative Colitis (UC)

INSIGHT-IBD Pragmatic Study

Wild Blueberries in Colitis

AIM-IBD: A Microbiome-Targeted Supplement in Mild-to-Moderate Ulcerative Colitis

FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Alpha Lipoic Acid in Ulcerative Colitis

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

TIDHI Mental Health in IBD Patients Study

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Phase 1b Clinical Study in Patients With Active Ulcerative Colitis

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease

Ex Vivo Comparison Of Combination Versus Single Therapeutic Pathway Inhibition In Human Intestinal Mucosa From Patients With Inflammatory Bowel Disease

A Direct Head-to-head Comparison of Ustekinumab With Infliximab for the Treatment of Ulcerative Colitis

The Efficacy of Lactobacillous Probiotic and Trace Elements in the Management of Ulcerative Colitis Patients the Patients Will be Recruited From Outpatient Clinic of Inflammatory Bowel Disease (IBD) of the National Hepatology and Tropical Medicine Research Institute NHTMRI, Cairo, Egypt

Safety, Tolerability and PK of ATTO 1091 in Healthy Adult Volunteers and Patients With Ulcerative Colitis

Palmitoylethanolamide in Ulcerative Colitis

Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis

Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors

Adapted Physical Activity for Persistent Fatigue in Patients With Inflammatory Bowel Disease in Remission

Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis